| Entry |
|
|---|
| Name |
Foslevodopa (JAN/USAN/INN) |
|---|
| Formula |
C9H12NO7P
|
|---|
| Exact mass |
277.0351
|
|---|
| Mol weight |
277.17
|
|---|
| Structure |
|
|---|
| Remark |
| Product (mixture): | D12494<JP> |
|
|---|
| Efficacy |
Antiparkinsonian |
|---|
| Comment |
Treatment of Parkinson's disease
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD
D11839 Foslevodopa (JAN/USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 18
1 C8y C 15.5804 -16.1394
2 C8y C 15.5804 -17.5367
3 C8x C 16.7682 -15.4407
4 O1a O 14.3228 -15.4407
5 C8x C 16.7682 -18.2354
6 O2b O 14.3228 -18.2354
7 C8y C 18.0258 -16.1394
8 C8x C 18.0258 -17.5367
9 C1b C 19.2834 -15.5106
10 C1c C 20.4712 -16.1394
11 C6a C 21.6589 -15.5106
12 N1a N 20.4712 -17.5367
13 O6a O 22.9165 -16.1394
14 O6a O 21.6589 -14.1132
15 P1b P 13.1572 -17.5371
16 O1c O 11.9219 -18.2235
17 O1c O 13.1795 -16.1701
18 O1c O 11.9448 -16.8371
BOND 18
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 5 8 1
8 7 9 1
9 9 10 1
10 10 11 1
11 10 12 1 #Up
12 11 13 1
13 11 14 2
14 7 8 2
15 6 15 1
16 15 16 1
17 15 17 1
18 15 18 2
|
|---|
